Pharming Group NV
AEX:PHARM

Watchlist Manager
Pharming Group NV Logo
Pharming Group NV
AEX:PHARM
Watchlist
Price: 0.7275 EUR -1.09%
Market Cap: 493.5m EUR
Have any thoughts about
Pharming Group NV?
Write Note

Pharming Group NV
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Pharming Group NV
Total Receivables Peer Comparison

Comparables:
PRQR
QURE
ARGX
MRUS
LVTX

Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Pharming Group NV
AEX:PHARM
Total Receivables
$48.2m
CAGR 3-Years
20%
CAGR 5-Years
12%
CAGR 10-Years
40%
ProQR Therapeutics NV
NASDAQ:PRQR
Total Receivables
€4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Uniqure NV
NASDAQ:QURE
Total Receivables
$5.3m
CAGR 3-Years
12%
CAGR 5-Years
121%
CAGR 10-Years
6%
argenx SE
XBRU:ARGX
Total Receivables
$655.6m
CAGR 3-Years
279%
CAGR 5-Years
159%
CAGR 10-Years
94%
Merus NV
NASDAQ:MRUS
Total Receivables
$3.9m
CAGR 3-Years
3%
CAGR 5-Years
1%
CAGR 10-Years
N/A
LAVA Therapeutics NV
NASDAQ:LVTX
Total Receivables
$1.7m
CAGR 3-Years
4%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Pharming Group NV's Total Receivables?
Total Receivables
48.2m USD

Based on the financial report for Sep 30, 2024, Pharming Group NV's Total Receivables amounts to 48.2m USD.

What is Pharming Group NV's Total Receivables growth rate?
Total Receivables CAGR 10Y
40%

Over the last year, the Total Receivables growth was 19%. The average annual Total Receivables growth rates for Pharming Group NV have been 20% over the past three years , 12% over the past five years , and 40% over the past ten years .

Back to Top